O
ABBV icon

OppenheimerFunds’s AbbVie ABBV Stock Holding History

OppenheimerFunds’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-100,000
Closed -$220K – 1738
2015
Q3 		$220K Buy
+100,000
New +$6.51M ﹤0.01% 917

Other funds holding ABBV

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

OppenheimerFunds's ABBV Position: Q1 2019 in Review

OppenheimerFunds increased its AbbVie (ABBV) stake by 14% in Q1 2019, buying an estimated $376K and bringing the position to 38,329 shares worth $3.09M. The position accounts for ﹤0.01% of the portfolio, ranked #814.

OppenheimerFunds first reported a position in ABBV in Q2 2013 and has held it in 24 quarters since. The position peaked at $345M in Q4 2014. 2,033 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.

  • OppenheimerFunds held 38,329 shares of AbbVie worth $3.09M as of Q1 2019.
  • OppenheimerFunds bought 4,593 AbbVie shares in Q1 2019, an estimated $376K.
  • AbbVie made up ﹤0.01% of OppenheimerFunds's portfolio in Q1 2019, its #814 holding.
  • OppenheimerFunds first reported a position in AbbVie in Q2 2013 and has held it in 24 quarters since.
  • OppenheimerFunds's AbbVie position peaked at $345M in Q4 2014.
  • 2,033 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.

Based on OppenheimerFunds's 13F filing for Q1 2019, filed 13 May 2019.